Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S
Department of Obstetrics and Gynecology, University of Trieste, Italy.
Eur J Obstet Gynecol Reprod Biol. 1997 May;73(1):31-6. doi: 10.1016/s0301-2115(97)02734-6.
To establish the physiologic changes in the coagulation and fibrinolytic systems during normal pregnancy and puerperium.
One hundred and seventeen normal pregnant women were investigated in a longitudinal study involving five measurements: blood samples were collected at 10, 20, 30, 36 weeks and on the second day puerperium and were assayed for prothrombin time (PT expressed in INR), activated partial thromboplastin time (PTT), fibrinogen (FBG), antithrombin III activity (AT III), protein C activity (PC), protein S activity (PS), prothrombin fragments 1+2 (F1+2), type 1 plasminogen activator inhibitor activity (PAI) and tissue-plasminogen activator antigen (t-PA). Student t-test, One Way Analysis of Variance (ANOVA) and Bonferroni test were used for statistical analysis. P<0.05 (two tails) was assumed to indicate a significant difference.
Fibrinogen concentrations were always increased with respect to controls (P<0.001), while protein S was always decreased, with values averaging 60% of those of controls from the 10th week of pregnancy onwards (P<0.001). Variance analysis showed a statistically significant increase with gestational age for procoagulant factors (INR: P<0.001; FBG: P<0.001), a reduction for anticoagulants (PC: P<0.0001; PS: P<0.0001), and a rise for F1+2 (P<0.0001). With regard to fibrinolysis, there was an increase both for t-PA (P<0.0001) and PAI-1 (P<0.0001) during pregnancy. The t-PA values were always comprised in the normal range. PAI-1 were increased with respect to control values starting from 31st week. The most significant variations in the procoagulants (expressed by PT and FBG) were recorded up to the 20th week (P<0.001); from the 30th week onwards, they remained stable until after the delivery. The same was true for protein S levels (P<0.001), except that the difference between the 10th and the 20th weeks was not statistically significant. The level of F1+2 gradually increased throughout pregnancy (P<0.001), and then fell in the puerperium (P<0.001).
The parameters showing the greatest variation during pregnancy were PT, FBG, PS, F1+2 and PAI-1. The existence of a hypercoagulable state in pregnancy was suggested by the increased levels of F1+2.
确定正常妊娠和产褥期凝血及纤溶系统的生理变化。
对117名正常孕妇进行纵向研究,包括五次测量:在妊娠10、20、30、36周及产后第二天采集血样,检测凝血酶原时间(以国际标准化比值[INR]表示的PT)、活化部分凝血活酶时间(PTT)、纤维蛋白原(FBG)、抗凝血酶III活性(AT III)、蛋白C活性(PC)、蛋白S活性(PS)、凝血酶原片段1+2(F1+2)、1型纤溶酶原激活物抑制剂活性(PAI)和组织型纤溶酶原激活物抗原(t-PA)。采用学生t检验、单因素方差分析(ANOVA)和Bonferroni检验进行统计分析。P<0.05(双侧)被认为表示有显著差异。
与对照组相比,纤维蛋白原浓度始终升高(P<0.001),而蛋白S始终降低,从妊娠第10周起其值平均为对照组的60%(P<0.001)。方差分析显示,促凝因子随孕周增加有统计学显著升高(INR:P<0.001;FBG:P<0.001),抗凝因子降低(PC:P<0.0001;PS:P<0.0001),F1+2升高(P<0.0001)。关于纤溶,孕期t-PA(P<0.0001)和PAI-1(P<0.0001)均升高。t-PA值始终在正常范围内。PAI-1从第31周起相对于对照值升高。促凝因子(以PT和FBG表示)最显著的变化记录在第20周之前(P<0.001);从第30周起,它们保持稳定直至分娩后。蛋白S水平也是如此(P<0.001),只是第10周和第20周之间的差异无统计学意义。F1+2水平在整个孕期逐渐升高(P<0.001),然后在产褥期下降(P<0.001)。
孕期变化最大的参数是PT、FBG、PS、F1+2和PAI-1。F1+2水平升高提示孕期存在高凝状态。